ActivX News Releases, Pre 2005

7/10/03	ActivX Biosciences Announces Agreement with Pfizer for Drug Profiling
6/30/03	ActivX Biosciences Awarded $1.1 Million Phase II SBIR/STTR Grant from National Cancer Institute for Establishing Drug Toxicity Profiles
1/07/03	ActivX Biosciences, Inc. announced today it has entered into a collaboration with Tokyo-based Sosei Co., Ltd.
11/19/02	ActivX Biosciences, Inc. Announces Kyorin Pharmaceutical Co., LTD. Makes Equity Investment in Company
8/08/02	ActivX Biosciences Announces Publication of Papers on Activity-Based Chemical Probes
8/01/02	ActivX Biosciences, Inc. Awarded SBIR/STTR Grant for Establishing Drug Toxicity Profiles with Activity-Based Proteomic Technology
6/04/02	Activx Biosciences, Inc. and Kyorin Pharmaceutical Co., LTD. Sign Drug Discovery Agreement for Diabetes Program.
7/31/01	Genomics Collaborative, Inc & ActivX Bioscience, Inc. sign proteomics discovery program in colon cancer
9/05/00	Activx Biosciences, Inc. announced today that Kathy Rooney has joined Activx as Vice President for Corporate Planning and Administration.
5/2000	Activx Biosciences, Inc. announced the successful signing of agreements with the Scripps Research Institute.
	Current Press